Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model
Alexandra Litvinchuk(Hope Center for Neurological Disorders), David M. Holtzman(Hope Center for Neurological Disorders), Tien‐Phat V. Huynh(Washington University in St. Louis), Rosemary J. Jackson(Harvard University), Ainsley C. Tran(Hope Center for Neurological Disorders), Caroline Massad Francis(Hope Center for Neurological Disorders), Jason D. Ulrich(Hope Center for Neurological Disorders), Bradley T. Hyman(Harvard University), Mary Beth Finn(Hope Center for Neurological Disorders), Yang Shi(Hope Center for Neurological Disorders), Patrick M. Sullivan(Veterans Health Administration), Tracy Cole(Ionis Pharmaceuticals (United States)), Melissa Manis(Hope Center for Neurological Disorders)
Cited by 80
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k